Skip to main content
. 2020 Nov 24;11(47):4401–4410. doi: 10.18632/oncotarget.27823

Figure 1. Survival outcomes in patients with Merkel cell carcinoma treated with an immune checkpoint inhibitor.

Figure 1

(A) Overall survival (in months) among 45 patients with Merkel cell carcinoma treated with an immune checkpoint inhibitor. Dotted lines represent 95% confidence intervals. (B) Overall survival among patients with Merkel cell carcinoma based on response to immune checkpoint inhibitor. CI = confidence interval, HR = hazard ratio.